Factoring in ANGPTL3 When LDL Is Refractory
- PMID: 33296565
- DOI: 10.1056/NEJMe2032798
Factoring in ANGPTL3 When LDL Is Refractory
Comment on
-
Evinacumab in Patients with Refractory Hypercholesterolemia.N Engl J Med. 2020 Dec 10;383(24):2307-2319. doi: 10.1056/NEJMoa2031049. Epub 2020 Nov 15. N Engl J Med. 2020. PMID: 33196153 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous